Author

Herman Wong

Observed names: H Wong, H. T. M. Wong, H. Wong, Herman T. Wong, Herman TM Wong

Observed institutions: Eli Lilly (United States), Chinese University of Hong Kong, Cancer Research UK, Hong Kong Sanatorium and Hospital, Prince of Wales Hospital, State Key Laboratory of Oncology in South China, University of Birmingham

OpenAlex ID: A5113851549

A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma

2005 · Winnie Yeo, Tony S. Mok, et al. · JNCI Journal of the National Cancer Institute · 591

Quantification and Utility of Monosialylated α-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma with Nondiagnostic Serum Total α-Fetoprotein

2002 · Terence CW Poon, Tony SK Mok, et al. · Clinical Chemistry · 57

An Intensive Surveillance Program Detected a High Incidence of Hepatocellular Carcinoma Among Hepatitis B Virus Carriers With Abnormal Alpha-Fetoprotein Levels or Abdominal Ultrasonography Results

2005 · Tony S.K. Mok, Winnie Yeo, et al. · Journal of Clinical Oncology · 39

Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy

2000 · W. Yeo, S. Zhong, et al. · Journal of Viral Hepatitis · 39

A Phase I–II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma

2002 · Tony S. K. Mok, Herman Wong, et al. · Cancer · 25

Transarterial Ethanol Ablation of Hepatocellular Carcinoma with Lipiodol–Ethanol Mixture: Phase II Study

2008 · Simon C.H. Yu, Edwin P. Hui, et al. · Journal of Vascular and Interventional Radiology · 23

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

2005 · Tony S.K. Mok, Kwok Chi Lam, et al. · Oncology · 14

A phase III study of doxorubicin (A) versus cisplatin (P)/ interferonα-2b (I)/ doxorubicin (A)/ fluorouracil (F) combination chemotherapy (PIAF) for inoperable hepatocellular carcinoma (HCC)

2004 · W. Yeo, B. Zee, et al. · Journal of Clinical Oncology · 12

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer

2004 · Tony S. K. Mok, Thomas W. T. Leung, et al. · Acta Oncologica · 8

Sequential Chemotherapy with Combination Irinotecan and Cisplatin Followed by Docetaxel for Treatment-Naïve Patients with Advanced Non-small Cell Lung Cancer

2007 · Tony S.K. Mok, Simon Ho, et al. · Journal of Thoracic Oncology · 2

The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis.

2011 · J. Chiu, Y. F. Tang, et al. · Journal of Clinical Oncology · 1

Gemcitabine-based combination chemotherapy for advanced non-small cell lung cancer: A new generation of therapy without cisplatin

2000 · T Mok, B Nguyen, et al. · Lung Cancer · 1

A phase II study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer ; A phase 2 study of neoadjuvant chemotherapy using combined taxane, anthracycline, and cyclophosphamide in high risk HER2-negative locally advanced breast cancer

2015 · Wyj Chiu, Rcy Leung, et al.

Acknowledgement to the Reviewers

2005 · Chih-Hung Hsu, Kun-Huei Yeh, et al. · Oncology

Author Index Vol. 68, 2005

2005 · Chih-Hung Hsu, Kun-Huei Yeh, et al. · Oncology

Works count: 15

Citation count: 812

H-index: 8

I10-index: 8